Luis Rojas
Optometrist · McKinney, TXNPI 1508247644
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $219,845 of the $308,528 with a category attached, or 71.3%. Johnson & Johnson Vision Care, Inc. accounts for 98.9% of it on its own, with 21 other manufacturers making up the rest. Among optometrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 903 payments — averaging $341.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$305K
- Alcon$422
- LKC Technologies, Inc.$382
- Biotissue Holdings Inc.$306
- Bausch & Lomb, A Division Of Bausch Health US, LLC$281
- Oyster Point Pharma, Inc.$230
- plus $2K from 16 others
What the payments were for
- Consulting fees$21,6437%
- Speaking & faculty fees$219,84571%
- Travel & lodging$48,02616%
- Food & beverage$19,0146%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 832 | $305,223 |
| Alcon | 10 | $422 |
| LKC Technologies, Inc. | 3 | $382 |
| Biotissue Holdings Inc. | 6 | $306 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $281 |
| Oyster Point Pharma, Inc. | 12 | $230 |
| Tarsus Pharmaceuticals, Inc. | 4 | $193 |
| Maculogix, Inc. | 1 | $181 |
| Sun Pharmaceutical Industries Inc. | 10 | $168 |
| Amgen | 1 | $155 |
| Harrow Eye, LLC | 2 | $141 |
| Dompe US, Inc. | 1 | $122 |
| Sanofi | 1 | $122 |
| Novartis | 1 | $117 |
| Coopervision Inc. | 2 | $109 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $97 |
| Sight Sciences, Inc. | 1 | $75 |
| AbbVie | 3 | $70 |
| Topcon Healthcare, Inc. | 2 | $43 |
| Bausch & Lomb Americas Inc. | 2 | $38 |
| Shire North American Group Inc | 2 | $35 |
| Shionogi Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$308,528 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 11 | $252 |
| Timolol Maleate | 29 | $144 |
| Brimonidine Tartrate | 18 | $117 |
Paid to pharmacies, not to this prescriber.
Other optometrist in McKinney
- Valerie BarnettMcKinney$35K
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Emile FadelAustin$225K
- Bridgitte LeeHouston$222K
- Phillip BrunsonHouston$214K
- Jill AutryBellaire$171K
- Stacie VirdenWaco$164K
- Richard PotvinBurleson$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.